Real-Time PCR Kit for Fetal RhD Blood Group Determination from Maternal Blood | Devyser ⁠RHD

Devyser RHD is a real-time PCR kit for determining the fetal RHD genotype from cell-free DNA in maternal plasma, enabling an accurate decision on which RhD-negative pregnant women truly need anti-D prophylaxis. Its single-exon design (Exon 4) with triplicate analysis and a GAPDH internal control using a dynamic range algorithm provides a simple procedure and a low rate of inconclusive results.

• Non-invasive fetal RhD blood group determination from maternal plasma cfDNA, from gestational week 10.
• Sensitivity 99.91% / specificity 99.86% - 12 years of data from Karolinska, covering more than 100,000 pregnant women.
• CE-IVDR Class D certification - the highest classification under European regulations.
• Helps reduce unnecessary anti-D injections by 37%.
• Pack size: 78 reactions for 25 samples / 390 reactions for 125 samples